European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

11:13 AM EDT, 10/19/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week lower late Monday morning, declining 0.65% to 1,891.99 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and medical device maker EDAP TMS (FOCL), which advanced 13% and 2.2% respectively. They were followed by internet browser company Opera (OPRA) and telecommunications company Nokia (NOK), which increased 1.1% and 0.9% respectively. The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and pharmaceutical company Sanofi (SNY), which dropped 4.8% and 2.1% respectively. They were followed by petroleum refiner Equinor (EQNR) and telecommunications company Ericsson (ERIC), which lost 1.9% and 1.7% respectively. The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which surged 125% and 14% respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and Mereo BioPharma Group (MREO), which were up 1.9% and 1.6% respectively. The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and utilities company National Grid (NGG), which fell 11% and 2.8% respectively. They were followed by software firm Endava (DAVA) and lender Barclays (BCS), which were off 2.4% and 2.3% respectively.